What type of drug is Copiktra?
Medically reviewed by Drugs.com. Last updated on Oct 15, 2018.
Official Answerby Drugs.com
Copiktra is a first-in-class, oral inhibitor of PI3K-delta and PI3K-gamma, two enzymes that boost survival of malignant B-cells (an overgrowth of a type of white blood cell in your immune system).
Copiktra (duvelisib), from Verastem Oncology, is used to treat two types of blood cancers in adults:
- relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL)
- relapsed or refractory follicular lymphoma (FL), when the patient has received at least two prior therapies.
CLL/SLL and FL are common types of indolent (slow-growing) non-Hodgkin lymphomas (iNHL).